Labeled glucose[6-17O] was used to evaluate differences in glucose metabolism between normal and tumor brain tissue. Experiments were performed using an intracranial 9L glioma model at 21.1 T magnet by observing changes of 17O-water and 17O-glucose MR peaks. The estimated rate of the total glucose metabolism in 9L glioma was approximately 11 times more than in the normal brain. Correspondingly, glucose metabolism rate is 7.5 times more in glioma at the enolase step. 17O MRI/MRS is an encouraging tool for assessing the differences in glucose metabolism in various cancer cells.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords